12964_2016_129_MOESM2_ESM.pdf (184.01 kB)
Additional file 2: Figure S2. of Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
journal contribution
posted on 2016-02-24, 05:00 authored by Sebastian Halbach, Zehan Hu, Christine Gretzmeier, Julia Ellermann, Franziska Wöhrle, Jörn Dengjel, Tilman Brummer(A/B) Western Blot quantification of Fig. 1d and 1G, n = 3, using FusionCapt 7.06 (Vilber Lourmat, Germany). (PDF 184 kb)
